CN Patent

CN116763726A — 一种盐酸西替利嗪口服溶液及其制备方法

Assigned to Shandong New Time Pharmaceutical Co Ltd · Expires 2023-09-19 · 3y expired

What this patent protects

本发明属于医药制剂领域，具体涉及一种盐酸西替利嗪口服溶液及其制备方法。本发明盐酸西替利嗪口服溶液含有盐酸西替利嗪、矫味剂、助溶剂、稳定剂、芳香剂、抑菌剂以及纯化水，通过优选辅料、优化制备工艺，使得本发明制备的口服溶液稳定性提高，具有服用方便、安全的特点，制备工艺简单，适于工业生产，便于市场推广。

USPTO Abstract

本发明属于医药制剂领域，具体涉及一种盐酸西替利嗪口服溶液及其制备方法。本发明盐酸西替利嗪口服溶液含有盐酸西替利嗪、矫味剂、助溶剂、稳定剂、芳香剂、抑菌剂以及纯化水，通过优选辅料、优化制备工艺，使得本发明制备的口服溶液稳定性提高，具有服用方便、安全的特点，制备工艺简单，适于工业生产，便于市场推广。

Drugs covered by this patent

Patent Metadata

Patent number
CN116763726A
Jurisdiction
CN
Classification
—
Expires
2023-09-19
Drug substance claim
No
Drug product claim
No
Assignee
Shandong New Time Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.